There is growing excitement about the potential shown by cell and gene therapies, particularly in rare diseases. First, though, these therapies face challenges both in …
The development of lyophilised products helps reduce the impact of cold chain management from refrigerated warehouses to point use. These products, typically, benefit from lower …
Cambridge, UK, 28 October 2021: Sphere Fluidics, a company that has developed and is commercialising single cell analysis systems underpinned by its proprietary picodroplet technology, …
Cancer continues to be a major burden on healthcare systems across the world, with global spending on therapies and supportive care drugs expected to reach …
While significant progress has been made carrying out CRISPR screens in immortalised cell lines, a more physiological and clinically relevant alternative is human primary cells, …
CAR-T cells have a genetically engineered T-cell receptor (TCR) that directs their binding to cancer cells. In first-generation CARs, the TCR was engineered to express …
Medicines Development for Global Health (MDGH) and the World Health Organisation Special Programme for Research and Training in Tropical Diseases (TDR) have announced that the …
Over the past seven years, Samsung BioLogics has constructed three state-of-the-art production facilities offering end-to-end integrated services to support the rapidly expanding clinical and commercial …
GERMAN RELIABILITY AND THOROUGHNESS Richter-Helm is a Hamburg, Germany-based contract development and manufacturing company specialized in products derived from bacteria and yeasts, with a proven …
